Cargando…
Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance
Olanzapine is a second-generation anti-psychotic drug used to prevent neuroinflammation in patients with schizophrenia. However, the long-term administration of olanzapine leads to insulin resistance (IR); the mechanisms of this effect remains poorly understood. Using cellular and rodent models of I...
Autores principales: | Li, Huqun, Peng, Shiyong, Li, Shihong, Liu, Shouqing, Lv, Yifan, Yang, Ni, Yu, Liangyu, Deng, Ya-Hui, Zhang, Zhongjian, Fang, Maosheng, Huo, Yunxiang, Chen, Ying, Sun, Taohua, Li, Weiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367387/ https://www.ncbi.nlm.nih.gov/pubmed/30733507 http://dx.doi.org/10.1038/s41598-018-36930-y |
Ejemplares similares
-
Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance
por: Li, Huqun, et al.
Publicado: (2016) -
The mechanisms underlying olanzapine-induced insulin resistance via the brown adipose tissue and the therapy in rats
por: Wang, Jing, et al.
Publicado: (2022) -
Association Between First Episode Schizophrenia, Metabolic Syndrome and Insulin Resistance-Related Proteins in Female Balb/C Mice
por: Sattar, Haseeb, et al.
Publicado: (2018) -
Acute Peripheral but Not Central Administration of Olanzapine Induces Hyperglycemia Associated with Hepatic and Extra-Hepatic Insulin Resistance
por: Girault, Elodie M., et al.
Publicado: (2012) -
Unraveling the Mechanisms Underlying Olanzapine-Induced Insulin Resistance
por: Irwin, Nigel, et al.
Publicado: (2013)